Funding for this research was provided by:
NIH (P30-CA76292)
Article History
Received: 30 August 2022
Accepted: 12 April 2023
First Online: 24 April 2023
Declarations
:
: Patients were originally consented to the Total Cancer Care Protocol, the Moffitt Cancer Center's institutional biorepository (MCC#14690; Advarra IRB Pro00014441). Methods development work for this study was carried out under a non-human subjects research determination (MCC#18426).
: Consent under MCC#14690 includes provisions for research on collected samples and publication of findings.
: The authors declare that they have no competing interests.